Van Tıp Dergisi, cilt.27, sa.4, ss.440-445, 2020 (TRDizin)
Introduction:Astheprevalenceandincidenceof diabetes mellitus (DM) continue to rise, the costs of the diagnosticstrategiesusedtodetectithavegained importance. The aim of this study was to analyze the cost of DM diagnostic strategies in a hospital setting.MaterialsandMethods:This cross-sectionalstudy included people over 18 years old with no previous DM diagnosisthatpresentedtotheinternalmedicine outpatient clinic for any reason and underwent serum glucose testing between December 1, 2012 and February 28, 2013. Decision treeanalysis was used to calculate weighted costs of the various diagnostic methods. Results:The study included 520 people. The prevalence of DM and pre-DM was 16.3% and 15.0%, respectively. During the study period, the total cost of all tests used was 2164.40 USD, the average cost per person was 4.14 USD, and the average cost per diagnosis was 25.46 USD. The most cost-effective strategy for the diagnosis of DM wasfastingplasmaglucose(FPG)andHbA1ctests requested together, while strategies using FPG testing were most cost-effective for the diagnosis of non-DM. Conclusion:The diagnostic strategies recommended in national and international guidelines are considerably less costly than many of the strategies used in our hospital. Costs could be lowered byensuring physicians are aware ofandimplementingmorecost-effectivediagnostic strategies.